HR Execs on the Move


 
Daon is an innovator in developing and deploying biometric authentication and identity assurance solutions worldwide. Daon has pioneered methods for securely and conveniently combining biometric and identity capabilities across multiple channels with large-scale deployments that span payments verification, digital banking, wealth, insurance, telcos, and securing borders and critical infrastructure. Daon`s IdentityX® platform provides an inclusive, trusted digital security experience, enabling the creation, authentication and recovery of a user`s identity and allowing businesses to conduct transactions with any consumer through any medium with total confidence.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.daon.com
  • 4097 Monument Corner Drive Suite 550
    Reston, VA USA 22030
  • Phone: 703.984.4000

Executives

Name Title Contact Details
Ralph Rodriguez
President and Chief Product Officer Profile
George Skaff
Senior Vice President of Marketing Profile

Similar Companies

Information Asset

Information Asset, LLC is a leading Data Governance and Privacy Solutions Firm.

S1

S1 Corporation delivers integrated financial services on an open platform for financial institutions, retailers and processors.

Infowit

The most customizable Cloud-based project management software built specifically for creative teams by creative people. Our #1 concern is making you successful.

BrewAI

Rapid business outcomes through deep learning autoML. #ai #artificialintelligence #deeplearning

Perthera

Perthera, Inc. is a service company that helps guide patients and their physicians to the best cancer treatment options available by bridging the gap between molecular testing and patient therapy. We provide a more complete view of the molecular pathways driving advanced stage cancer than any other company. By combining genomics, proteomics and clinical history, Perthera delivers a comprehensive molecular analysis of a patient`s tumor and identifies the best available FDA approved therapies and clinical trials for each individual patient.